Shandong Weigao (01066) Announces Share Repurchase and Updated Treasury Share Holding

Bulletin Express01-23

On 23 January 2026, Shandong Weigao Group Medical Polymer Company Limited repurchased 282,000 H shares on the Hong Kong Stock Exchange. The highest repurchase price reached HKD 5.19 per share, while the lowest price was HKD 5.1, resulting in a total consideration of approximately HKD 1,446,320.

Following this transaction, the number of treasury shares increased from 38,043,600 to 38,325,600. The total number of issued shares remained at 4,522,332,324, with the number of issued shares excluding treasury shares adjusted to 4,484,006,724.

According to the filing, the repurchase was conducted under a mandate approved on 27 May 2025, authorizing up to 451,560,392 shares for potential repurchase. As of the latest update, 31,677,200 shares have been repurchased under this mandate, which accounts for 7.0151% of the issued shares (excluding treasury shares) on the date the resolution was passed. A moratorium period on new share issuance or the sale or transfer of treasury shares applies until 22 February 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment